Tag Archives: patentability

Partner, Chris Mammen will be speaking at the the Advanced Patent Law Institute in Palo Alto on Dec 6-7, 2018. The APLI offers a results-oriented, in-depth look at the latest developments in patent law and practice. Co-organized by BCLT and Stanford Law School, it presents an expert faculty of judges, academics, litigators, patent prosecutors, and senior IP counsel from major corporations. Chris

Capable of identifying novel compounds for therapeutic use, AI is saving time and costs in a process that can take around 10 to 15 years and billions of pounds to complete. For the pharmaceutical industry, which has traditionally relied on patents to protect innovation and fund R&D, this should be good news, but is an

The preview-version of the EPO’s Guidelines for Examination is out now (link here), and, for the first time ever, there is specific guidance on patenting AI applications – Are there any surprises in the Guidelines? Earlier this year the European Patent Office (“EPO”) held its first ever conference on patenting artificial intelligence (“AI”). Following intensive

In April’s issue of Pharma Times Magazine, partner Cullen Taylor explores how new machine learning technologies may have far-reaching, unexpected effects on IP and patent law. Cullen’s article looks at how AI is likely to accelerate the process of developing drugs and identifying patients who can benefit from them. It outlines patentability challenges for policy makers as well

New York IP partner, Ted Mlynar was interviewed by Law360 for its recent article “What IP Attys Need to Know About Blockchain“. Ted comments on the application of blockchain technology, not solely in the financial sector, but across a wide range of industries. In this interview, Ted also discusses the blockchain patent filing trends of big businesses and the issue

By judgement of January 3rd, 2017, the Turin Court of Appeal delivered a monumental decision in a longstanding patent dispute concerning the validity and infringement of patents relating to an Electronic Program Guide (EPG) for digital and satellite television. The patented technology related to a system for selecting television channels, to be implemented in televisions,

By decision of December 2nd, 2016, No 24658, Industriale Chimica S.r.l. vs Bayer Pharma AG, the Italian Supreme Court ruled on the infringement by equivalence and on the patentability of intermediates. Infringement by equivalence For the first time the Supreme Court has been asked to assess the infringement by equivalence under Article 52 of the

We’re delighted to introduce our ITC Section 337 series. The series provides updates on recent U.S. International Trade Commission (ITC) Section 337 investigations as well as other timely ITC developments that affect your business. What’s ITC and how can it affect my business? ITC Investigations under 19 U.S.C. § 1337 (“Section 337”) are initiated by companies

Chris Mammen recently interviewed Berkeley Law professors Narechania and McCrary about some of the IP applications of blockchain. This short video touches upon the following points: What is blockchain? Does it have broader applications outside Finance? Who is the inventor and why is his/her/their identity important? How might ownership of a core set of blockchain patents play out in

The America Invents Act (AIA) became law roughly five years ago, and with its implementation came new administrative proceedings by which companies may challenge the validity of patents at the U.S. Patent and Trademark Office. Rather than establishing a single uniform procedure that permits challenges to any patent based on any statutory ground, however, Congress

All rights reserved. "Hogan Lovells" or the “firm” refers to the international legal practice, including Hogan Lovells International LLP and Hogan Lovells US LLP, each of which is a separate legal entity. Attorney Advertising. Prior results do not guarantee a similar outcome.